Christine Rousseau

Chembio Diagnostics has appointed Christine Rousseau to the newly created position of vice president of corporate development, effective immediately. She will focus on the company's point-of-care infectious disease diagnostics strategy and execution, including HIV self-testing, and fever and tropical diseases, as well as collaborations leveraging Chembio's DPP technology platform and expertise. Rousseau was previously at the Bill & Melinda Gates Foundation, most recently as senior program officer of Global Health, Integrated Technology Solutions. Prior to that, she was a research scientist and faculty member at the University of Washington.